Quinoxaline Derivatives as Antiviral Agents: A Systematic Review

被引:111
作者
Montana, Marc [1 ,2 ]
Montero, Vincent [1 ]
Khoumeri, Omar [1 ]
Vanelle, Patrice [1 ,3 ]
机构
[1] Aix Marseille Univ, Lab Pharmacochim Radicalaire, Inst Chim Radicalaire ICR, CNRS,UMR 7273, F-13005 Marseille, France
[2] Hop Nord Marseille, AP HM, Oncopharma, F-13005 Marseille, France
[3] AP HM, Serv Cent Qualite & Informat Pharmaceut SCQIP, F-13005 Marseille, France
关键词
quinoxaline; antiviral; SAR; biological applications; chemistry; VIRUS NS3/4A PROTEASE; INFLUENZA-A; RNA-BINDING; NS1; PROTEIN; INHIBITORS; DESIGN; CYTOTOXICITY; SOFOSBUVIR; RIBAVIRIN;
D O I
10.3390/molecules25122784
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: In recent decades, several viruses have jumped from animals to humans, triggering sizable outbreaks. The current unprecedent outbreak SARS-COV-2 is prompting a search for new cost-effective therapies to combat this deadly pathogen. Suitably functionalized polysubstituted quinoxalines show very interesting biological properties (antiviral, anticancer, and antileishmanial), ensuring them a bright future in medicinal chemistry. Objectives: Focusing on the promising development of new quinoxaline derivatives as antiviral drugs, this review forms part of our program on the anti-infectious activity of quinoxaline derivatives. Methods: Study compiles and discusses recently published studies concerning the therapeutic potential of the antiviral activity of quinoxaline derivatives, covering the literature between 2010 and 2020. Results: A final total of 20 studies included in this review. Conclusions: This review points to a growing interest in the development of compounds bearing a quinoxaline moiety for antiviral treatment. This promising moiety with different molecular targets warrants further investigation, which may well yield even more encouraging results regarding this scaffold.
引用
收藏
页数:19
相关论文
共 69 条
[1]  
Ahmad I., 2015, International Journal Of Pharmacy And Pharmaceutical Sciences, V7, P19
[2]   Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer [J].
Ahmad, Irshad ;
Shagufta .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 :375-386
[3]   Direct and catalytic synthesis of quinoxaline derivatives from epoxides and ene-1,2-diamines [J].
Antoniotti, S ;
Duñach, E .
TETRAHEDRON LETTERS, 2002, 43 (22) :3971-3973
[4]   Straightforward access to pyrazines, piperazinones, and quinoxalines by reactions of 1,2-diaza-1,3-butadienes with 1,2-diamines under solution, solvent-free, or solid-phase conditions [J].
Aparicio, Domitila ;
Attanasi, Orazio A. ;
Filippone, Paolino ;
Ignacio, Roberto ;
Lillini, Samuele ;
Mantellini, Fabio ;
Palacios, Francisco ;
Santos, Jesus M. de los .
JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (16) :5897-5905
[5]  
Badri T., 2020, MOLLUSCUM CONTAGIOSU
[6]  
Blair W., 2016, F1000RES, V5, pF1000, DOI [10.12688/f1000research.7665.1, DOI 10.12688/F1000RESEARCH.7665.1]
[7]   Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses [J].
Brideau, RJ ;
Knechtel, ML ;
Huang, A ;
Vaillancourt, VA ;
Vera, EE ;
Oien, NL ;
Hopkins, TA ;
Wieber, JL ;
Wilkinson, KF ;
Rush, BD ;
Schwende, FJ ;
Wathen, MW .
ANTIVIRAL RESEARCH, 2002, 54 (01) :19-28
[8]   Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives [J].
Briguglio, Irene ;
Loddo, Roberta ;
Laurini, Erik ;
Fermeglia, Maurizio ;
Piras, Sandra ;
Corona, Paola ;
Giunchedi, Paolo ;
Gavini, Elisabetta ;
Sanna, Giuseppina ;
Giliberti, Gabriele ;
Ibba, Cristina ;
Farci, Pamela ;
La Colla, Paolo ;
Pricl, Sabrina ;
Carta, Antonio .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 105 :63-79
[9]  
Brown D J., 2004, The Chemistry of Heterocyclic Compounds
[10]   Gallium(III) triflate-catalyzed synthesis of quinoxaline derivatives [J].
Cai, Jing-Jing ;
Zou, Jian-Ping ;
Pan, Xiang-Qiang ;
Zhang, Wei .
TETRAHEDRON LETTERS, 2008, 49 (52) :7386-7390